Hantz Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $608K | Sell |
1,366
-18
| -1% | -$8.01K | 0.01% | 497 |
|
|
2025
Q1 | $671K | Buy |
1,384
+126
| +10% | +$61.1K | 0.01% | 473 |
|
|
2024
Q4 | $507K | Sell |
1,258
-2,286
| -65% | -$921K | 0.01% | 500 |
|
|
2024
Q3 | $1.65M | Buy |
3,544
+69
| +2% | +$32.1K | 0.03% | 365 |
|
|
2024
Q2 | $1.63M | Buy |
3,475
+3,437
| +9,045% | +$1.61M | 0.03% | 354 |
|
|
2024
Q1 | $16K | Hold |
38
| – | – | ﹤0.01% | 783 |
|
|
2023
Q4 | $15K | Hold |
38
| – | – | ﹤0.01% | 766 |
|
|
2023
Q3 | $13K | Hold |
38
| – | – | ﹤0.01% | 777 |
|
|
2023
Q2 | $13K | Buy |
+38
| New | +$13K | ﹤0.01% | 757 |
|
|
2022
Q1 | – | Sell |
-91
| Closed | -$20K | – | 1126 |
|
|
2021
Q4 | $20K | Sell |
91
-9
| -9% | -$1.98K | ﹤0.01% | 624 |
|
|
2021
Q3 | $18K | Sell |
100
-2,395
| -96% | -$431K | ﹤0.01% | 631 |
|
|
2021
Q2 | $503K | Buy |
2,495
+656
| +36% | +$132K | 0.02% | 391 |
|
|
2021
Q1 | $395K | Buy |
1,839
+692
| +60% | +$149K | 0.02% | 392 |
|
|
2020
Q4 | $271K | Buy |
1,147
+755
| +193% | +$178K | 0.01% | 381 |
|
|
2020
Q3 | $107K | Buy |
+392
| New | +$107K | 0.01% | 426 |
|